Author Question: A patient has hemolytic anemia. An instrument printout reveals a reticulocyte count of 8, marked ... (Read 65 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
A patient has hemolytic anemia. An instrument printout reveals a reticulocyte count of 8, marked polychromasia and moderate schistocytes, and an MCV of 88 fl. What can be concluded about the bone marrow response to this hemolytic anemia?
 
  a. It is adequate.
  b. It is not adequate for the degree of hemolysis.
  c. The reticulocyte count indicates that the marrow is responding at its maximum rate.
  d. There is not enough information to determine whether bone marrow response is adequate.

Question 2

A patient with a bleeding problem is complaining to her physician about excessive fatigue. Physical examination reveals a thin, pale woman with pale mucosal membranes. Significant CBC findings include an MCV of 70 fl.
 
  Based on these findings, follow-up testing should be ordered for:
 
  a. Iron studies
  b. Vitamin B12 and folate assays
  c. Coagulation screening tests
  d. A bone marrow aspirate



DylanD1323

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

Correct Answer: B

Answer to Question 2

Correct Answer: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library